Anti-Murine IP-10 (CXCL10) 0 ComentariosSubmit a Review Detalles del Producto Nùmero de Catalogo 500-P129 Descripcion Source: Polyclonal Rabbit Preparation: Produced from sera of rabbits pre-immunized with highly pure (>98%) recombinant mIP-10. Anti-Murine IP-10 specific antibody was purified by affinity chromatography employing immobilized mIP-10 matrix. Immunogen: E.coli derived Recombinant Murine IP-10 (CXCL10) (PeproTech catalog# 250-16) Sandwich ELISA: To detect mIP-10 by sandwich ELISA (using 100 μl/well antibody solution) a concentration of 0.5 - 2.0 μg/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with PeproTech’s Biotinylated Anti-Murine IP-10 (500-P129Bt) as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant mIP-10. Western Blot: To detect mIP-10 by Western Blot analysis this antibody can be used at a concentration of 0.1-0.2 µg/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant mIP-10 is 1.5-3.0 ng/lane, under either reducing or non-reducing conditions. Note: Additional applications tested on a lot-to-lot basis. Please contact Technical Support for more information. crossreactivity: Mouse References SDS Búsqueda del CoA Product Line Country Of Origin: USA Not for human use. Research Interest COVID-19 Angiogenesis/Cardiovascular Chemotaxis Immune System Inflammation Neurobiology Proliferation Wound Healing Allergy Transplantation product.subtitle.recentcitations Primer autor Lopez-Rodriguez, A B Titulo Acute systemic inflammation exacerbates neuroinflammation in Alzheimer's disease: IL-1β drives amplified responses in primed astrocytes and neuronal network dysfunction. Citar Alzheimer's &Amp; Dementia : The Journal Of The Alzheimer's Association; 17(10) pg1735-1755 PudMed id 34080771 Primer autor Sotolongo, J Titulo Host innate recognition of an intestinal bacterial pathogen induces TRIF-dependent protective immunity. Citar The Journal of Experimental Medicine; 208(13) pg2705-16 PudMed id 22124111 Primer autor Nakashima, H Titulo A novel combination immunotherapy for cancer by IL-13Rα2-targeted DNA vaccine and immunotoxin in murine tumor models. Citar Journal of immunology (Baltimore, Md. : 1950); 187(10) pg4935-46 PudMed id 22013118
